The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637

Abstract Background Gastric cancer (GC) remains a global health challenge due to its high morbidity, late-stage diagnosis, and limited therapeutic options. long non-coding RNA PANDAR has been implicated in tumorigenesis across multiple cancers, yet its role in GC pathogenesis and diagnostic utility...

Full description

Saved in:
Bibliographic Details
Main Authors: Weikang Su, Zhiling Zhong, Huazhi Li, Lingjia Meng, Xinqiang Zhong
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Hereditas
Subjects:
Online Access:https://doi.org/10.1186/s41065-025-00511-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342220298092544
author Weikang Su
Zhiling Zhong
Huazhi Li
Lingjia Meng
Xinqiang Zhong
author_facet Weikang Su
Zhiling Zhong
Huazhi Li
Lingjia Meng
Xinqiang Zhong
author_sort Weikang Su
collection DOAJ
description Abstract Background Gastric cancer (GC) remains a global health challenge due to its high morbidity, late-stage diagnosis, and limited therapeutic options. long non-coding RNA PANDAR has been implicated in tumorigenesis across multiple cancers, yet its role in GC pathogenesis and diagnostic utility is still unclear. The purpose of this study is to elucidate the diagnostic value of serum PANDAR and its regulatory mechanisms in GC progression. Methods lncRNA PANDAR levels were quantified in serum from 112 GC patients and 98 benign controls using RT-qPCR. The diagnostic value of lncRNA PANDAR was analyzed by ROC curve. Functional experiments (CCK-8, Transwell assays) and dual-luciferase reporter assays were conducted in HGC-27 and BGC-823 cells to explore the function of PANDAR in cell proliferation, migration, and invasion. The interaction between PANDAR and miR-637 was validated via bioinformatics prediction and co-inhibition assay. Results Serum PANDAR was significantly upregulated in GC patients (P < 0.0001) and exhibited high diagnostic accuracy (AUC = 0.913). Elevated PANDAR associated with advanced TNM stage (P = 0.047), lymph node metastasis (P = 0.023), and digestive system history (P = 0.035). PANDAR knockdown suppressed GC cell proliferation, migration, and invasion, effects reversed by co-inhibition of miR-637. Conclusions lncRNA PANDAR is a promising non-invasive diagnostic indicator of GC, and may serve as a biomarker for GC diagnosis and therapy. lncRNA PANDAR regulates the progression of GC through sponge miR-637.
format Article
id doaj-art-4a409677d70c4ef1ba80064f8d0aa662
institution Kabale University
issn 1601-5223
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Hereditas
spelling doaj-art-4a409677d70c4ef1ba80064f8d0aa6622025-08-20T03:43:27ZengBMCHereditas1601-52232025-07-01162111210.1186/s41065-025-00511-7The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637Weikang Su0Zhiling Zhong1Huazhi Li2Lingjia Meng3Xinqiang Zhong4Department of Gastroenterology, The First Affiliated Hospital of Jinan UniversityDepartment of Gastroenterology, The Second Hospital of Dalian Medical UniversityGeneral Surgery Department, Beijing Anzhen Hospital, Capital Medical UniversityDepartment of Emergency Medicine, Putuo Hospital, Shanghai University of Traditional Chinese MedicineDepartment of Gastrointestinal Surgery, Huanggang Central Hospital Affiliated to Yangtze UniversityAbstract Background Gastric cancer (GC) remains a global health challenge due to its high morbidity, late-stage diagnosis, and limited therapeutic options. long non-coding RNA PANDAR has been implicated in tumorigenesis across multiple cancers, yet its role in GC pathogenesis and diagnostic utility is still unclear. The purpose of this study is to elucidate the diagnostic value of serum PANDAR and its regulatory mechanisms in GC progression. Methods lncRNA PANDAR levels were quantified in serum from 112 GC patients and 98 benign controls using RT-qPCR. The diagnostic value of lncRNA PANDAR was analyzed by ROC curve. Functional experiments (CCK-8, Transwell assays) and dual-luciferase reporter assays were conducted in HGC-27 and BGC-823 cells to explore the function of PANDAR in cell proliferation, migration, and invasion. The interaction between PANDAR and miR-637 was validated via bioinformatics prediction and co-inhibition assay. Results Serum PANDAR was significantly upregulated in GC patients (P < 0.0001) and exhibited high diagnostic accuracy (AUC = 0.913). Elevated PANDAR associated with advanced TNM stage (P = 0.047), lymph node metastasis (P = 0.023), and digestive system history (P = 0.035). PANDAR knockdown suppressed GC cell proliferation, migration, and invasion, effects reversed by co-inhibition of miR-637. Conclusions lncRNA PANDAR is a promising non-invasive diagnostic indicator of GC, and may serve as a biomarker for GC diagnosis and therapy. lncRNA PANDAR regulates the progression of GC through sponge miR-637.https://doi.org/10.1186/s41065-025-00511-7lncRNA PANDARmiR-637Gastric cancerDiagnostic biomarkerTumor progression
spellingShingle Weikang Su
Zhiling Zhong
Huazhi Li
Lingjia Meng
Xinqiang Zhong
The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637
Hereditas
lncRNA PANDAR
miR-637
Gastric cancer
Diagnostic biomarker
Tumor progression
title The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637
title_full The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637
title_fullStr The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637
title_full_unstemmed The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637
title_short The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637
title_sort diagnostic and predictive value of lncrna pandar in gastric cancer and its regulation of gastric cancer progression via mir 637
topic lncRNA PANDAR
miR-637
Gastric cancer
Diagnostic biomarker
Tumor progression
url https://doi.org/10.1186/s41065-025-00511-7
work_keys_str_mv AT weikangsu thediagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT zhilingzhong thediagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT huazhili thediagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT lingjiameng thediagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT xinqiangzhong thediagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT weikangsu diagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT zhilingzhong diagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT huazhili diagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT lingjiameng diagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637
AT xinqiangzhong diagnosticandpredictivevalueoflncrnapandaringastriccanceranditsregulationofgastriccancerprogressionviamir637